ArticlebioRxiv : the preprint server for biology2024

AAV-based delivery of RNAi targeting Ataxin-2 improves survival, strength, and pathology in mouse models of rapidly and slowly progressive sporadic ALS.

Defne A Amado et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.